Exploring the dual character of metformin in Alzheimers disease
Despite promising research, it is important to exercise caution when considering the potential benefits of GLP-1 agonists beyond diabetes and obesity
If you found this episode helpful, follow Clinical Capsules or leave a quick rating or review
Importantly, FIH studies also provide essential information for the design of Phase 2 trials , including decisions related to dosing schedules, administration frequency and safety monitoring strategies
In 2019, the FDA approved bremelanotide under the brand name Vyleesi as a treatment for acquired, generalized HSDD in premenopausal women
The biggest winners will be the clinics, med spas, telehealth platforms, and practitioners building in this space now